-transparent.png){kind=logo}
Replacement of the 3,4-dialkoxyphenyl substructure common to a number of PDE4 inhibitors with a 2-alkyl-7-methoxybenzofuran unit is described. This substitution can result in either enhancement or substantial reductions in PDE4 inhibitory activity depending on the system to which it is applied. An in vitro SAR study of a potent series of 4-(2-heteroaryl-ethyl)-benzoiurans 26 is also presented.
Related Publications
D G McGarry, and
J R Regan, and
F A Volz, and
C Hulme, and
K J Moriarty, and
S W Djuric, and
J E Souness, and
B E Miller, and
J J Travis, and
D M Sweeney
February 2013,
Bioorganic & medicinal chemistry letters,
D G McGarry, and
J R Regan, and
F A Volz, and
C Hulme, and
K J Moriarty, and
S W Djuric, and
J E Souness, and
B E Miller, and
J J Travis, and
D M Sweeney
April 2012,
Bioorganic & medicinal chemistry letters,
D G McGarry, and
J R Regan, and
F A Volz, and
C Hulme, and
K J Moriarty, and
S W Djuric, and
J E Souness, and
B E Miller, and
J J Travis, and
D M Sweeney
October 2008,
British journal of pharmacology,
D G McGarry, and
J R Regan, and
F A Volz, and
C Hulme, and
K J Moriarty, and
S W Djuric, and
J E Souness, and
B E Miller, and
J J Travis, and
D M Sweeney
January 2007,
Bioorganic & medicinal chemistry,
D G McGarry, and
J R Regan, and
F A Volz, and
C Hulme, and
K J Moriarty, and
S W Djuric, and
J E Souness, and
B E Miller, and
J J Travis, and
D M Sweeney
June 2002,
Bioorganic & medicinal chemistry letters,
D G McGarry, and
J R Regan, and
F A Volz, and
C Hulme, and
K J Moriarty, and
S W Djuric, and
J E Souness, and
B E Miller, and
J J Travis, and
D M Sweeney
October 1998,
Bioorganic & medicinal chemistry letters,
D G McGarry, and
J R Regan, and
F A Volz, and
C Hulme, and
K J Moriarty, and
S W Djuric, and
J E Souness, and
B E Miller, and
J J Travis, and
D M Sweeney
November 2011,
Bioorganic & medicinal chemistry letters,
D G McGarry, and
J R Regan, and
F A Volz, and
C Hulme, and
K J Moriarty, and
S W Djuric, and
J E Souness, and
B E Miller, and
J J Travis, and
D M Sweeney
January 2003,
Current opinion in pulmonary medicine,
D G McGarry, and
J R Regan, and
F A Volz, and
C Hulme, and
K J Moriarty, and
S W Djuric, and
J E Souness, and
B E Miller, and
J J Travis, and
D M Sweeney
September 1999,
Expert opinion on investigational drugs,
D G McGarry, and
J R Regan, and
F A Volz, and
C Hulme, and
K J Moriarty, and
S W Djuric, and
J E Souness, and
B E Miller, and
J J Travis, and
D M Sweeney
October 1998,
Bioorganic & medicinal chemistry letters,
